Results 1 to 10 of about 411,574 (298)

IGFBP1 as a metabolic-neurodegenerative biomarker in spinocerebellar ataxia type 3. [PDF]

open access: yesExp Ther Med
Chiu C   +8 more
europepmc   +1 more source

Intersecting Molecular Pathways in Cardiovascular Disease and Diabetes Mellitus: Emerging Roles of Inflammation and Therapeutics. [PDF]

open access: yesDiabetes Metab Res Rev
Anagnostopoulou L   +13 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Synthetic insulin-like growth factor II

Biochemical and Biophysical Research Communications, 1985
Human insulin-like growth factor II with 67 amino acid residues and three disulfide bridges has been synthesized by the solid-phase method. Homogeneity of the synthetic product is ascertained by chromatofocusing, high performance liquid chromatography and amino acid analysis.
C H, Li   +3 more
openaire   +2 more sources

Insulin‐Like Growth Factor II Effects Mediated through Insulin‐Like Growth Factor II Receptors

Acta Paediatrica, 1990
ABSTRACT. Insulin‐like growth factor II (IGF‐II) resembles the homologous peptide insulin‐like growth factor I (IGF‐I) in that it stimulates cellular growth in vitro. This effect is generally believed to be mediated through IGF type 1 receptors; the role of the IGF type 2 receptor remains, as yet, unknown.
M, Tally, K, Hall
openaire   +2 more sources

Home - About - Disclaimer - Privacy